UPDATE 1-U.S. FDA panel backs Valeant psoriasis drug with risk management

July 19 (Reuters) - Valeant Pharmaceuticals International

Inc's experimental drug to treat the skin disorder

psoriasis should be approved as long as certain measures are put

in place to mitigate the...

Read more